UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Cancer, 2015-10, Vol.121 (20), p.3631-3638

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation

Liver transplantation, 2013-06, Vol.19 (6), p.594-601

2013

Link zum Volltext

Verfügbarkeit prüfen

Analyzing Longitudinal Data from Glaucoma Trials

Therapeutic innovation & regulatory science, 2023-03, Vol.57 (2), p.365-371

Dinh, Phillip

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials

PloS one, 2015-03, Vol.10 (3), p.e0121632-e0121632

2015

Link zum Volltext

Verfügbarkeit prüfen

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant

The journal of clinical psychiatry, 2011-09, Vol.72 (9), p.1166

2011

Link zum Volltext

Verfügbarkeit prüfen

A Transitional Probability Model for Parkinson’s Disease Motor States With Applications to Missing Data

Therapeutic innovation & regulatory science, 2019-07, Vol.53 (4), p.420-425

Dinh, Phillip

2019

Link zum Volltext

Verfügbarkeit prüfen

Sex-related differences in QTc effects potential of drugs

Reviews on recent clinical trials, 2011-09, Vol.6 (3), p.220

2011

Link zum Volltext

Verfügbarkeit prüfen

Statistical Challenges in the Analyses of Bone Mineral Density in Pediatric Populations

Therapeutic innovation & regulatory science, 2015-07, Vol.49 (4), p.569-575

Dinh, Phillip

2015

Link zum Volltext

Verfügbarkeit prüfen

Using multiple imputation to estimate cumulative distribution functions in longitudinal data analysis with data missing at random

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2013-09, Vol.12 (5), p.260-267

Dinh, Phillip

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2016, Vol.150 (1), p.134-144.e10

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

Journal of hepatology, 2016-04, Vol.64 (4), p.773-780

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

Hepatology (Baltimore, Md.), 2012-12, Vol.56 (6), p.2018-2026

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations

Clinical neuropharmacology, 2019-09, Vol.42 (5), p.149

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2014-04, Vol.146 (4), p.980-988.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients

Journal of hepatology, 2014-04, Vol.60 (4), p.715-722

2014

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

Journal of hepatology, 2014-12, Vol.61 (6), p.1228-1237

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.505-513

2013

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)

Journal of glaucoma, 2021-06, Vol.30 (6), p.473

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B

Journal of hepatology, 2015-11, Vol.63 (5), p.1086-1092

2015

Link zum Volltext

Verfügbarkeit prüfen

Handling Baselines in Repeated Measures Analyses with Missing Data at Random

Journal of biopharmaceutical statistics, 2011-03, Vol.21 (2), p.326-341

2011

Link zum Volltext

Verfügbarkeit prüfen

Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate

Journal of hepatology, 2015-05, Vol.62 (5), p.1033-1039

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

Hepatology international, 2015-04, Vol.9 (2), p.243-250

2015

Link zum Volltext

Verfügbarkeit prüfen

Viral Suppression and Cirrhosis Regression with Tenofovir Disoproxil Fumarate in Asians with Chronic Hepatitis B

Digestive diseases and sciences, 2015-01, Vol.60 (1), p.260-268

2015

Link zum Volltext

Verfügbarkeit prüfen

Repeated Measures Analyses in Clinical Trials with Titration Visits

Therapeutic innovation & regulatory science, 2009-09, Vol.43 (5), p.595-602

2009

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results

Clinical gastroenterology and hepatology, 2017, Vol.15 (1), p.e44-e44

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(70)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(46)
Humans
(43)
Female
(25)
Male
(23)
Adult
(20)
Middle Aged
(16)
Hepatitis B, Chronic - Drug Therapy
(14)
Gastroenterology & Hepatology
(13)
Pharmacology & Pharmacy
(11)
Aged
(10)
Antiviral Agents - Therapeutic Use
(10)
Gastroenterology And Hepatology
(10)
Treatment Outcome
(10)
Adenine - Analogs & Derivatives
(9)
Double-Blind Method
(9)
Adenine - Therapeutic Use
(8)
Clinical Trials
(8)
Medicine
(8)
Organophosphonates - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation

Analyzing Longitudinal Data from Glaucoma Trials

Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant

A Transitional Probability Model for Parkinson’s Disease Motor States With Applications to Missing Data

Sex-related differences in QTc effects potential of drugs

Statistical Challenges in the Analyses of Bone Mineral Density in Pediatric Populations

Using multiple imputation to estimate cumulative distribution functions in longitudinal data analysis with data missing at random

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)

Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B

Handling Baselines in Repeated Measures Analyses with Missing Data at Random

Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

Viral Suppression and Cirrhosis Regression with Tenofovir Disoproxil Fumarate in Asians with Chronic Hepatitis B

Repeated Measures Analyses in Clinical Trials with Titration Visits

A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results

Suchergebnisse filtern